featured
KEYNOTE-522 Updated Results: Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab or Placebo for Early-Stage TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: